CELLDA

Prostate cancer is a prevalent and often life-altering disease that affects millions of men worldwide. It is the second most commonly diagnosed cancer among men, following lung cancer. This condition demands our attention, research, and innovative solutions to improve early detection, diagnosis, and treatment. At Cellda AB, we are dedicated to pioneering advancements in prostate cancer diagnostics to enhance patient outcomes and reduce the burden of this disease on individuals and their families... We are a passionate team of professionals driven by a singular mission: to redefine cancer diagnostics. With a focus on our first product for prostate cancer, we have dedicated ourselves to innovating and advancing healthcare. Our commitment to excellence extends to every aspect of our work, from developing state-of-the-art technology to collaborating with experts in pathology and software development... We are dedicated to pioneering cancer diagnostics. Our team, comprising experts in..

Also known as: Cellda AB

Primary location: Uppsala Sweden